Evidence map›Paper›PMID 39038814›Full record

ArticleJournal of chemical information and modeling2024

EnzyACT: A Novel Deep Learning Method to Predict the Impacts of Single and Multiple Mutations on Enzyme Activity.

Gen Li, Ning Zhang, Xiaowen Dai, Long Fan

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Applications and limitations of AI tools in enzyme design.Protein science : a publication of the Protein Society · 2026
    Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Gen LiProduction and R&D Center I of LSS, GenScript (Shanghai) Biotech Co.,Ltd., Shanghai 200131, China.ORCID 0000-0002-6862-5547
Ning ZhangProduction and R&D Center I of LSS, GenScript Biotech Corporation, Nanjing 211122, China.
Xiaowen DaiProduction and R&D Center I of LSS, GenScript Biotech Corporation, Nanjing 211122, China.
Long FanProduction and R&D Center I of LSS, GenScript (Shanghai) Biotech Co.,Ltd., Shanghai 200131, China.ORCID 0000-0001-8938-2225

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enzyme engineering involves the customization of enzymes by introducing mutations to expand the application scope of natural enzymes. One limitation of that is the complex interaction between two key properties, activity and stability, where the enhancement of one often leads to the reduction of the other, also called the trade-off mechanism. Although dozens of methods that predict the change of protein stability upon mutations have been developed, the prediction of the effect on activity is still in its early stage. Therefore, developing a fast and accurate method to predict the impact of the mutations on enzyme activity is helpful for enzyme design and understanding of the trade-off mechanism. Here, we introduce a novel approach, EnzyACT, a deep learning method that fuses graph technique and protein embedding to predict activity changes upon single or multiple mutations. Our model combines graph-based techniques and language models to predict the activity changes. Moreover, EnzyACT is trained on a new curated data set including both single- and multiple-point mutations. When benchmarked on multiple independent data sets, it shows uniform performance on problems affected by mutations. This work also provides insights into the impact of distant mutations within activity design, which could also be useful for predicting catalytic residues and developing improved enzyme-engineering strategies.

Indexed as

Deep LearningEnzymesMutationModels, MolecularProtein EngineeringEnzymes

Identifiers

PMID39038814
PMCPMC11323264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.